Aminoglycosides
Mechanism of Action -- The aminoglycoside (AG) antibiotics enter the Gram negative cell by the porin channel.  After passage through the cell wall, they are taken up by an energy-dependent transport mechanism into the bacteria proper.  They then bind to the 30S subunit of the bacterial ribosome, thus inhibiting protein synthesis.
The aminoglycosides are bactericidal in their action and are used primarily in the treatment of Gram negative infections.

Resistance may develop to the AG by changes in the 30S subunit, preserving its functionality but reducing the ability of the antibiotic to bind to it.  There are some cases of resistance in which the 30S subunit actually becomes altered so as to require the presence of the AG in order to function properly.

Specific AGs include Neomycin, Streptomycin, Kanamycin (these three have a limited spectrum of activity -- they are ineffective against Serratia and Pseudomonas spp.), Gentamicin, Tobramycin, Netilmicin, and Amikacin (these last two have the broadest spectrum of activity and are more effective again resistant organisms).  They are poorly absorbed from the GI tract and are used only parenterally.

Therapeutics -- The AGs are used for streptococcal infections, tularemia (a plague-like infection caused by Francisella (Pasteurella) tularensis -- with ticks or the deer fly as the disease vector), plague, tuberculosis, UTI, sepsis, and meningitis (they must be given intrathecally or directly into the cerebral ventricles).

Adverse Effects

Go To Next Topic (Quinolones and Sulphonamides)